25 results
10-K
2018 FY
GOSS
Gossamer Bio Inc
22 Mar 19
Annual report
4:45pm
reasonable efforts to develop and commercialize at least one licensed product in the United States and in at least two countries in the European Union … in the United States, in at least two countries in the European Union, and in Japan, in each case for at least one of the initial indications of UC or CD
424B4
GOSS
Gossamer Bio Inc
8 Feb 19
Prospectus supplement with pricing info
4:40pm
States. In the European Union, the European Medicines Agency’s, or the EMA’s, Committee for Orphan Medicinal Products grants orphan drug designation … condition affecting not more than five in 10,000 persons in the European Union. We have received orphan drug designation in the United States
S-1
GOSS
Gossamer Bio Inc
21 Dec 18
IPO registration
4:39pm
will be recovered from sales in the United States. In the European Union, the European Medicines Agency’s, or the EMA’s, Committee for Orphan Medicinal … -threatening or chronically debilitating condition affecting not more than five in 10,000 persons in the European Union. We have received orphan drug
S-1/A
woelv3
23 Jan 19
IPO registration (amended)
4:39pm
DRS/A
t1w4swnru5ue156ek
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
5m7bad3ayzj3zv
11 Oct 18
Draft registration statement
12:00am
8-K
EX-10.1
gsipk 7mn
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
S-1
EX-10.17
kz35pbac
21 Dec 18
IPO registration
4:39pm
DRS
EX-10.13
09xp7cmvsaqc2vb6pl
11 Oct 18
Draft registration statement
12:00am
S-1/A
EX-1.1
8rd9 bgwtveoxdqj42r
23 Jan 19
IPO registration (amended)
4:39pm
8-K
EX-1.1
ph8b9l b9b
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-1.2
jcye8g8ykaqy9vile3
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
DRS
EX-10.14
z0cxpv2 54f2
11 Oct 18
Draft registration statement
12:00am
S-1
EX-10.18
dna r779ma
21 Dec 18
IPO registration
4:39pm
8-K
EX-10.1
mvzvv1fbg0 gi
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am